Dr. Kiran K Rajasenan MD Hematologist

Dr. Kiran Rajasenan is a hematologist in Wexford, Pennsylvania and is affiliated with multiple hospitals in the area, including Forbes Regional Hospital and UPMC Passavant. He received his medical degree from Allegheny University of the Health Sciences and has been in practice for 18 years. Dr. Rajasenan accepts several types of health insurance, listed below. He is one of 33 doctors at Forbes Regional Hospital and one of 15 at UPMC Passavant who specialize in Hematology.

Are you Dr. Rajasenan? Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Hospital Affiliation

UPMC Passavant

Forbes Regional Hospital
High performing in Cancer

Education & Medical Training

Allegheny General Hospital-Western Pennsylvania Hospital
Residency, Internal Medicine, 1996–1999

Allegheny General Hospital-Western Pennsylvania Hospital
Fellowship, Medical Oncology, 1999–2000

University of Pittsburgh Medical Center
Fellowship, Hematology/Oncology, 2000–2001

Allegheny University of the Health Sciences
Class of 1996

Certifications & Licensure

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

PA State Medical License
Active through 2014

Awards, Honors & Recognition

Pittsburgh Magazine Top Doc 2013, Best Doctors

Pittsburgh Magazine Top Doc 2012, Best Doctors

Leo Criep Award 2012, UPMC

Leo Criep Award 2009, UPMC

Publications & Presentations

A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer.
Sehgal, R., Lembersky, B.C., Rajasenan, K.K., Crandall, T.L., Balaban, E.P., Pinkerton, R.A., Kane, P., Schmotzer, A., Zeh, H., Potter, D.M., Ramanathan, R.K.

Splenic small B-cell lymphoma with IGH/BCL3 translocation.
Soma, L.A., Gollin, S.M., Remstein, E.D., Ketterling, R.P., Flynn, H.C., Rajasenan, K.K., Swerdlow, S.H.

A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas.
Lo, S. S., Khorana, A. A., Javle, M., Simon, S., Kiefer, G., Rajasenan, K., Wang, H., Hantel, A., Shayne, M., Hwang, J., Schmotzer, A., Ramanathan, R. K.

Insurances Accepted

  • Aetna HMO
  • Highmark BCBS ClassicBlue
  • Multiplan PHCS PPO
  • BCBS Blue Card PPO
  • HealthAmerica HealthAssurance PPO
  • Multiplan PPO
  • Aetna Choice POS II
  • CIGNA Open Access
  • CIGNA PPO
  • Great West PPO
  • Highmark BCBS PPOBlue
  • United Healthcare - Direct Options PPO
  • CIGNA HMO
  • Humana ChoiceCare Network PPO
  • United Healthcare - Direct Choice Plus POS

Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support


See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Nearby Hematologists

See all Hematologists in Pennsylvania

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.